Oligonucleotide Synthesis Market size to grow by USD 1.70 Bn; Agilent Technologies Inc. and Ajinomoto Co. Inc. emerge as key vendors -- Technavio

NEW YORK, Oct. 12, 2022 /PRNewswire/ -- The "Oligonucleotide Synthesis Market by End-user and Geography - Forecast and Analysis 2022-2026" report has been added to Technavio's offering. According to the report, the market size is expected to accelerate at a CAGR of 11.09% between 2021 and 2026 and register an incremental growth of USD 1.70 billion during the forecast period. Technavio identifies Agilent Technologies Inc., Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biotage AB, and Danaher Corp. among others as key vendors in the market. The report has considered various factors such as patient population, the incidence rate of the disease, revenue generated by vendors, current healthcare expenditure, per capita income, disposable income, and other factors to estimate the size of the market. Understand the scope of our full report by Downloading Free Sample PDF Report.

The market is driven by factors such as increasing research activities in pharmaceutical and biotechnology sectors, increasing use of oligonucleotides as therapeutic and diagnostic tools, and the emergence of technological innovations in oligonucleotide synthesis. However, regulatory issues associated with oligonucleotide therapeutics will reduce the growth potential in the market. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help businesses improve their market position, Technavio's report provides a detailed analysis of around 25 vendors operating in the market. The report covers the following areas:

• Oligonucleotide Synthesis Market size
• Oligonucleotide Synthesis Market trends
• Oligonucleotide Synthesis Market industry analysis

• End-user 
• Pharmaceutical and Biotechnology Companies
• Research and Academic Institutes
• Diagnostic Laboratories
• Hospitals

The pharmaceutical and biotechnology companies are the major end-users in the market. The increasing number of drug development research and clinical trials across the globe is driving the demand for oligonucleotides in the segment. The market growth in the segment will be significant over the forecast period.

• Geography 
• North America
• Europe
• Asia
• Rest Of World (ROW)

North America will account for 43% of the global market share during the forecast period. The presence of key market vendors such as Agilent Technologies, Thermo Fisher Scientific, Danaher, General Electric, and GenScript Biotech offering customized oligonucleotide products is a major factor driving the growth of the regional market. In addition, the growing prevalence of rare diseases and the presence of a large number of genetic research institutes are fostering the growth of the oligonucleotide synthesis market in North America.

Gain deeper insights into the growth contribution of each business segment. Identify potential areas to invest in over the forecast period and gain confidence. Read Our Report Sample Now

Some of the major vendors of the oligonucleotide synthesis market include:

• Agilent Technologies Inc.: The company offers oligonucleotide systhesis products under its brand SurePrint.
• Alnylam Pharmaceuticals Inc.: The company offers oligonucleotide systhesis products such as Onpattro, Givlaari.
• Bio Synthesis Inc: The company offers oligonucleotide systhesis product namely BIIB078.
• Biotage AB: This segment focuses developing and selling world leading solutions for separation and synthesis of new substances.
• Eurofins Scientific SE: The company offers oligonucleotide systhesis products through Integrated DNA Technology.
• Ajinomoto Co. Inc.
• Danaher Corp.
• General Electric Co
• Ionis Pharmaceuticals Inc.
• Kaneka Corp.
• LGC Ltd.
• Maravai LifeSciences Holdings Inc.
• Merck and Co. Inc.
• Mettler Toledo International Inc.
• QIAGEN NV
• Sarepta Therapeutics Inc
• Synbio Technologies
• Syngene International Ltd.
• Thermo Fisher Scientific Inc.
• Biogen Inc.

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will assist oligonucleotide synthesis market growth during the next five years
• Estimation of the oligonucleotide synthesis market size and its contribution to the parent market
• Predictions on upcoming trends and changes in consumer behavior
• The growth of the oligonucleotide synthesis market
• Analysis of the market's competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of oligonucleotide synthesis market vendors

• Oligonucleotide Therapeutics Market by Application, Technology, and Region - Forecast and Analysis 2020-2024
• Nucleic Acid Labeling Market by Application, End-user, and Geography - Forecast and Analysis 2022-2026

1 Executive Summary

• 1.1 Market overview 
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem 
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition 
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary 
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry 
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition 
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

• 5.1 Market segments 
• Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
• Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)

• 5.2 Comparison by End-user 
• Exhibit 26: Chart on Comparison by End-user
• Exhibit 27: Data Table on Comparison by End-user

• 5.3 Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2021-2026 (%)

• 5.4 Research and academic institutes - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Research and academic institutes - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Research and academic institutes - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Research and academic institutes - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Research and academic institutes - Year-over-year growth 2021-2026 (%)

• 5.5 Diagnostic laboratories - Market size and forecast 2021-2026 
• Exhibit 36: Chart on Diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Diagnostic laboratories - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Diagnostic laboratories - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Diagnostic laboratories - Year-over-year growth 2021-2026 (%)

• 5.6 Hospitals - Market size and forecast 2021-2026
• Exhibit 40: Chart on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Hospitals - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Hospitals - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Hospitals - Year-over-year growth 2021-2026 (%)

• 5.7 Market opportunity by End-user 
• Exhibit 44: Market opportunity by End-user ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 46: Chart on Market share by geography 2021-2026 (%)
• Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.9 France - Market size and forecast 2021-2026
• Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)

• 7.10 China - Market size and forecast 2021-2026
• Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape 
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption 
• Exhibit 89: Overview on factors of disruption

• 9.4 Industry risks 
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered 
• Exhibit 91: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 92: Matrix on vendor position and classification

• 10.3 Agilent Technologies Inc. 
• Exhibit 93: Agilent Technologies Inc. - Overview
• Exhibit 94: Agilent Technologies Inc. - Business segments
• Exhibit 95: Agilent Technologies Inc. - Key news
• Exhibit 96: Agilent Technologies Inc. - Key offerings
• Exhibit 97: Agilent Technologies Inc. - Segment focus

• 10.4 Alnylam Pharmaceuticals Inc. 
• Exhibit 98: Alnylam Pharmaceuticals Inc. - Overview
• Exhibit 99: Alnylam Pharmaceuticals Inc. - Product / Service
• Exhibit 100: Alnylam Pharmaceuticals Inc. - Key news
• Exhibit 101: Alnylam Pharmaceuticals Inc. - Key offerings

• 10.5 Biogen Inc. 
• Exhibit 102: Biogen Inc. - Overview
• Exhibit 103: Biogen Inc. - Product / Service
• Exhibit 104: Biogen Inc. - Key offerings

• 10.6 Danaher Corp. 
• Exhibit 105: Danaher Corp. - Overview
• Exhibit 106: Danaher Corp. - Business segments
• Exhibit 107: Danaher Corp. - Key news
• Exhibit 108: Danaher Corp. - Key offerings
• Exhibit 109: Danaher Corp. - Segment focus

• 10.7 Eurofins Scientific SE 
• Exhibit 110: Eurofins Scientific SE - Overview
• Exhibit 111: Eurofins Scientific SE - Business segments
• Exhibit 112: Eurofins Scientific SE - Key news
• Exhibit 113: Eurofins Scientific SE - Key offerings
• Exhibit 114: Eurofins Scientific SE - Segment focus

• 10.8 LGC Ltd. 
• Exhibit 115: LGC Ltd. - Overview
• Exhibit 116: LGC Ltd. - Product / Service
• Exhibit 117: LGC Ltd. - Key offerings

• 10.9 Maravai LifeSciences Holdings Inc. 
• Exhibit 118: Maravai LifeSciences Holdings Inc. - Overview
• Exhibit 119: Maravai LifeSciences Holdings Inc. - Business segments
• Exhibit 120: Maravai LifeSciences Holdings Inc. - Key offerings
• Exhibit 121: Maravai LifeSciences Holdings Inc. - Segment focus

• 10.10 Merck and Co. Inc. 
• Exhibit 122: Merck and Co. Inc. - Overview
• Exhibit 123: Merck and Co. Inc. - Business segments
• Exhibit 124: Merck and Co. Inc. - Key news
• Exhibit 125: Merck and Co. Inc. - Key offerings
• Exhibit 126: Merck and Co. Inc. - Segment focus

• 10.11 Sarepta Therapeutics Inc 
• Exhibit 127: Sarepta Therapeutics Inc - Overview
• Exhibit 128: Sarepta Therapeutics Inc - Product / Service
• Exhibit 129: Sarepta Therapeutics Inc - Key offerings

• 10.12 Thermo Fisher Scientific Inc. 
• Exhibit 130: Thermo Fisher Scientific Inc. - Overview
• Exhibit 131: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 132: Thermo Fisher Scientific Inc. - Key news
• Exhibit 133: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 134: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 135: Inclusions checklist
• Exhibit 136: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 137: Currency conversion rates for US$

• 11.4 Research methodology 
• Exhibit 138: Research methodology
• Exhibit 139: Validation techniques employed for market sizing
• Exhibit 140: Information sources

• 11.5 List of abbreviations 
• Exhibit 141: List of abbreviations

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio